Kendall Capital Partners — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Frequency TherapeuticsJul 2019SEC filingmedium confidence
BiotechWoburn, US
David Lucchino(Executive Officer, Director)Christopher R. Loose(Executive Officer)
BoardMarc Kozin(Director)Marc Cohen(Director)Timothy Barberich(Director)
Board seatRobert Langer· per SEC Form D · $62M raise · filed Jul 2019
Co-investorsvenBio PartnersAlexandria
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.